(Q35691919)

9 August 2017

1 reference

title

Acute graft versus host disease following liver transplantation: the enemy within (English)

1 reference

9 August 2017

main subject

liver transplantation

1 reference

Anna L Taylor

1

1 reference

9 August 2017

Paul Gibbs

series ordinal

2

1 reference

9 August 2017

J Andrew Bradley

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

American Journal of Transplantation

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

466-474

1 reference

Immunohematologic complications of ABO-unmatched liver transplants

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Liver transplant-associated graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Treatment of graft-versus-host disease after liver transplantation with basiliximab followed by bowel resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Unusual onset of chronic graft-versus-host disease after adult living-related liver transplantation from a homozygous donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Cutaneous lesions as the presenting sign of acute graft-versus-host disease following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Microchimerism, GVHD, and tolerance in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Acute graft-vs-host disease: pathobiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Alloreactive killer cells: hindrance and help for haematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Cell migration, chimerism, and graft acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Infliximab for steroid‐refractory acute GVHD: A case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

Resident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00406.X

10.1111/J.1600-6143.2004.00406.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference